Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The B-Side of Cancer Immunity: The Underrated Tune
Anne Largeot, Giulia Pagano, Susanne Gonder, et al.
Cells (2019) Vol. 8, Iss. 5, pp. 449-449
Open Access | Times Cited: 151

Showing 1-25 of 151 citing articles:

Inflammation and tumor progression: signaling pathways and targeted intervention
Huakan Zhao, Lei Wu, Guifang Yan, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 1636
Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer: the NABUCCO trial
Nick van Dijk, Alberto Gil-Jimenez, Karīna Siliņa, et al.
Nature Medicine (2020) Vol. 26, Iss. 12, pp. 1839-1844
Closed Access | Times Cited: 323
Tumor-Infiltrating Lymphocytes and Their Prognostic Value in Cutaneous Melanoma
Fabienne Maibach, Hassan Sadozai, S. Morteza Seyed Jafari, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 237
Tumor microenvironment components: Allies of cancer progression
Pablo Igor Ribeiro Franco, Arthur Perillo Rodrigues, Liliana Borges de Menezes, et al.
Pathology - Research and Practice (2019) Vol. 216, Iss. 1, pp. 152729-152729
Closed Access | Times Cited: 201
Chemokines and their Receptors: Multifaceted Roles in Cancer Progression and Potential Value as Cancer Prognostic Markers
Hà Thị Thu, Chang Hoon Lee, Jungsook Cho
Cancers (2020) Vol. 12, Iss. 2, pp. 287-287
Open Access | Times Cited: 189
STING agonist-based treatment promotes vascular normalization and tertiary lymphoid structure formation in the therapeutic melanoma microenvironment
Manoj Chelvanambi, Ronald J. Fecek, Jennifer L. Taylor, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 2, pp. e001906-e001906
Open Access | Times Cited: 122
Cancer Vaccine Therapeutics: Limitations and Effectiveness—A Literature Review
Mariusz Kaczmarek, Justyna Poznańska, Filip Fechner, et al.
Cells (2023) Vol. 12, Iss. 17, pp. 2159-2159
Open Access | Times Cited: 106
Metabolic Modulation of Immunity: A New Concept in Cancer Immunotherapy
Luana Guerra, Lynn Bonetti, Dirk Brenner
Cell Reports (2020) Vol. 32, Iss. 1, pp. 107848-107848
Open Access | Times Cited: 133
Regulatory B cells in cancer
Daniel Michaud, Colleen R. Steward, Bhalchandra Mirlekar, et al.
Immunological Reviews (2020) Vol. 299, Iss. 1, pp. 74-92
Open Access | Times Cited: 131
The oncogenic and clinical implications of lactate induced immunosuppression in the tumour microenvironment
Conall Hayes, Claire L. Donohoe, Maria Davern, et al.
Cancer Letters (2020) Vol. 500, pp. 75-86
Open Access | Times Cited: 127
The balance between breast cancer and the immune system: Challenges for prognosis and clinical benefit from immunotherapies
Constantin N. Baxevanis, Sotirios P. Fortis, Sonia A. Perez
Seminars in Cancer Biology (2019) Vol. 72, pp. 76-89
Closed Access | Times Cited: 118
Dissecting the single-cell transcriptome network underlying esophagus non-malignant tissues and esophageal squamous cell carcinoma
Zhencong Chen, Mengnan Zhao, Jiaqi Liang, et al.
EBioMedicine (2021) Vol. 69, pp. 103459-103459
Open Access | Times Cited: 87
The impact of hypoxia on immune state in cancer
Keywan Mortezaee, Jamal Majidpoor
Life Sciences (2021) Vol. 286, pp. 120057-120057
Closed Access | Times Cited: 70
Balance between immunoregulatory B cells and plasma cells drives pancreatic tumor immunity
Bhalchandra Mirlekar, Yan Wang, Sirui Li, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 9, pp. 100744-100744
Open Access | Times Cited: 42
Immune System and Hepatocellular Carcinoma (HCC): New Insights into HCC Progression
Maria Kotsari, Vassiliki Dimopoulou, John Koskinas, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11471-11471
Open Access | Times Cited: 41
Multi-omics analysis reveals NNMT as a master metabolic regulator of metastasis in esophageal squamous cell carcinoma
Qi Huang, Haiming Chen, Dandan Yin, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 14
Resolving the Paradox of Colon Cancer Through the Integration of Genetics, Immunology, and the Microbiota
Marine Fidelle, Satoru Yonekura, Marion Picard, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 69
Proliferating CD8+ T Cell Infiltrates Are Associated with Improved Survival in Glioblastoma
Ileana S. Mauldin, Jasmin Jo, Nolan A. Wages, et al.
Cells (2021) Vol. 10, Iss. 12, pp. 3378-3378
Open Access | Times Cited: 56
Myeloid-derived suppressor cells regulate the immunosuppressive functions of PD-1−PD-L1+ Bregs through PD-L1/PI3K/AKT/NF-κB axis in breast cancer
Min Liu, Feng Wei, Jian Wang, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 5
Open Access | Times Cited: 53
PARP inhibition and immune modulation: scientific rationale and perspectives for the treatment of gynecologic cancers
Elizabeth K. Lee, Panagiotis A. Konstantinopoulos
Therapeutic Advances in Medical Oncology (2020) Vol. 12
Open Access | Times Cited: 51
NF-κB in Cancer Immunity: Friend or Foe?
Guilhem Lalle, Julie Twardowski, Yenkel Grinberg‐Bleyer
Cells (2021) Vol. 10, Iss. 2, pp. 355-355
Open Access | Times Cited: 50
Histamine in cancer immunology and immunotherapy. Current status and new perspectives
María de la Paz Sarasola, Mónica A. Táquez Delgado, Melisa B. Nicoud, et al.
Pharmacology Research & Perspectives (2021) Vol. 9, Iss. 5
Open Access | Times Cited: 47
Large-Scale Single-Cell and Bulk Sequencing Analyses Reveal the Prognostic Value and Immune Aspects of CD147 in Pan-Cancer
Jingwei Zhang, Zeyu Wang, Xun Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 38
Baseline circulating unswitched memory B cells and B-cell related soluble factors are associated with overall survival in patients with clear cell renal cell carcinoma treated with nivolumab within the NIVOREN GETUG-AFU 26 study
Lucía Carril-Ajuria, Aude Desnoyer, Maxime Meylan, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 5, pp. e004885-e004885
Open Access | Times Cited: 34
Ten‐eleven translocation‐2 inactivation restrains IL‐10‐producing regulatory B cells to enable antitumor immunity in hepatocellular carcinoma
Lu Zhou, Ronghua Liu, Yining Wang, et al.
Hepatology (2022) Vol. 77, Iss. 3, pp. 745-759
Closed Access | Times Cited: 30
Page 1 - Next Page

Scroll to top